Living medicine thins biofilms in pig ventilation tubes
Researchers in Barcelona tested a living medicine on pigs to thin drug-resistant biofilms on ventilation tubes.
The experimental treatment involved inhaling a genetically modified bacterium made to attack resistant bacteria layers on hospital breathing tube surfaces. This approach represents the first time such therapy has worked in pigs alongside previous mouse studies.
The engineered Mycoplasma pneumoniae bacterium was loaded with genes to dissolve sugars holding biofilms together while targeting resistant bugs. Scanning electron microscope images confirmed the biofilm thickness decreased significantly after the animals breathed in the mist.
Dr. Irene Rodríguez-Arce explained that this Trojan horse strategy delivers therapeutic molecules instead of causing harm to the lung tissue. The study showed no damage occurred to the animals when researchers examined the lungs afterward.
The results indicate the method could advance to testing in humans who rely on tubes to stay alive. Adding the living medicine to intravenous antibiotics might further improve the experimental treatment effectiveness over time.
“Our work represents a different line of attack, and one we badly need”

